Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Sep 13, 2023 FORM 3 SUBMISSION
3 Sep 13, 2023 FORM 3 SUBMISSION
8-K Sep 12, 2023 8-K
8-K Sep 8, 2023 8-K
425 Aug 31, 2023 425
10-Q Aug 3, 2023 10-Q
EFFECT Aug 1, 2023
424B3 Aug 1, 2023 424B3
CORRESP Jul 31, 2023
S-4/A Jul 31, 2023 S-4/A
CORRESP Jul 17, 2023
S-4/A Jul 17, 2023 S-4/A
UPLOAD Jul 6, 2023
CORRESP Jun 22, 2023
S-4/A Jun 22, 2023 S-4/A
UPLOAD Jun 13, 2023
425 May 19, 2023 425
8-K May 19, 2023 8-K
SC 13G May 15, 2023 SC 13G
10-Q May 15, 2023 10-Q
S-4 May 15, 2023 S-4
8-A12B May 3, 2023 8-A12B
425 May 3, 2023 425
8-K May 3, 2023 8-K
10-K/A May 1, 2023 10-K/A
← Newer Page 12 of 27 · 661 filings Older →